UC Berkeley

In February, the USPTO's Patent Trial and Appeal Board stopped UC's bid for IP underpinning the most lucrative applications of genome editing.

The researchers used this approach to show how non-coding variation associated with human immune dysfunction alters context-specific gene programs. 

Doudna will get $2.1 million to set up the Center for Genome Editing and Recording, and Zhang will get $1.1 million to develop tools for RNA interrogation.

Researchers led by Jennifer Doudna found that the architecture of the Cas1-Cas2 integrase contributes to bacterial adaptive immunity.

A new study led by UC-Berkeley scientists shows that an inhibitor protein from a Listeria bacteriophage can block Cas9 from interacting with DNA.

Berkeley researchers described variants of the Cas13a CRISPR protein that could allow for simultaneous detection of two different RNA molecules.

Reinstating the CRISPR patent interference with the Broad Institute would allow UC to argue that Jennifer Doudna and Emmanuelle Charpentier invented it first.